Return to Trial Database

BTCRC-LUN18-153

A Randomized Phase II Trial of Adjuvant Pembrolizumab Versus Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial BTCRC-LUN18-153 being conducted in.

Fred & Pamela Buffett Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Masonic Cancer Center, University of Minnesota

Moffitt Cancer Center

Penn State Cancer Institute

Providence Cancer Institute

Rutgers Cancer Institute

University of Illinois Cancer Center

University of Iowa Holden Comprehensive Cancer Center

University of Virginia Cancer Center